Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menitorix Booster vs Infanrix Hexa in Toddlers
NCT00323050Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Primary completion
- Mar 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Hib-MenC-TT in Serogroup C meningococcal disease (MenC), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Nov 2004; status: completed.
02
Drugs
Hib-MenC-TT
03
Conditions
Serogroup C meningococcal disease (MenC)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00323050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323050.